BionTech | The Business Standard
Skip to main content
  • Home
  • Economy
  • Analysis
  • Bangladesh
  • World
  • Sports
  • Glitz
  • Feature
  • Long Read
  • PSI
  • Games
  • epaper
  • More
    • COVID-19
    • Top News
    • Companies
    • Environment
    • Infograph
    • Interviews
    • Markets
    • Special Stories
    • Multimedia/videos
    • Offbeat
    • Panorama
    • Thoughts
    • Science
    • Splash
    • Tech
    • Subscribe
    • Archive
  • বাংলা
The Business Standard
tbs
SUNDAY, JANUARY 17, 2021
SUNDAY, JANUARY 17, 2021
  • Home
  • Economy
  • Analysis
  • Bangladesh
  • World
  • Sports
  • Glitz
  • Feature
  • Long Read
  • PSI
  • Games
  • epaper
  • More
    • COVID-19
    • Top News
    • Companies
    • Environment
    • Infograph
    • Interviews
    • Markets
    • Special Stories
    • Multimedia/videos
    • Offbeat
    • Panorama
    • Thoughts
    • Science
    • Splash
    • Tech
    • Subscribe
    • Archive
  • বাংলা

BionTech

Coronavirus chronicle

BioNTech says can make mutation-beating coronavirus vaccine in six weeks

German biotechnology company BioNTech says that they can make mutation-beating Covid vaccine in six weeks, reported NDTV via Agence France-Presse

Coronavirus chronicle

BioNTech says 140,000 vaccinated in Britain so far

World

Pfizer-BioNTech apply for EU emergency authorization for Covid-19 vaccine

World

Couple’s dream vaccine: Pfizer’s success announcement makes founders $2B richer

Coronavirus chronicle

Germany asks military to provide safe storage for Covid-19 vaccines

Coronavirus chronicle

Pfizer, BioNTech initial vaccine results impress, but scientists remain cautious

Coronavirus chronicle

Why Pfizer’s ultra-cold Covid-19 vaccine will not be at the local pharmacy any time soon

Coronavirus chronicle

Covid-19 vaccine: First 'milestone' vaccine offers 90% protection

Coronavirus chronicle

Pfizer, BioNTech propose expanding Covid-19 vaccine trial to 44,000 volunteers

Coronavirus chronicle

Shanghai Fosun Pharma, Sinopharm Group sign deal to supply BioNTech coronavirus vaccine candidate

Coronavirus chronicle

BioNTech, Pfizer begin German part of Covid-19 vaccine study

Coronavirus chronicle

BioNTech, China's Fosun strikes deal to potentially supply 10 mln doses of Covid-19 vaccine

Coronavirus chronicle

Pfizer, BioNTech to supply 120 mln doses of coronavirus vaccine to Japan

  • Show More
The Business Standard
Top
  • Home
  • Entertainment
  • Sports
  • About Us
  • Bangladesh
  • International
  • Comment Policy
  • Contact Us
  • Economy
  • Sitemap
  • RSS

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - [email protected]

For advertisement- [email protected]

Copyright © 2021 THE BUSINESS STANDARD All rights reserved. Technical Partner: RSI Lab